These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15123626)

  • 1. Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis.
    Lilja L; Johansson JU; Gromada J; Mandic SA; Fried G; Berggren PO; Bark C
    J Biol Chem; 2004 Jul; 279(28):29534-41. PubMed ID: 15123626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the fusion pore conductance during exocytosis by cyclin-dependent kinase 5.
    Barclay JW; Aldea M; Craig TJ; Morgan A; Burgoyne RD
    J Biol Chem; 2004 Oct; 279(40):41495-503. PubMed ID: 15273248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
    Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C
    Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18.
    Fletcher AI; Shuang R; Giovannucci DR; Zhang L; Bittner MA; Stuenkel EL
    J Biol Chem; 1999 Feb; 274(7):4027-35. PubMed ID: 9933594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
    Ko J; Humbert S; Bronson RT; Takahashi S; Kulkarni AB; Li E; Tsai LH
    J Neurosci; 2001 Sep; 21(17):6758-71. PubMed ID: 11517264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
    Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
    J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.
    Odemuyiwa SO; Ilarraza R; Davoine F; Logan MR; Shayeganpour A; Wu Y; Majaesic C; Adamko DJ; Moqbel R; Lacy P
    Immunology; 2015 Apr; 144(4):641-8. PubMed ID: 25346443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5 promotes insulin exocytosis.
    Lilja L; Yang SN; Webb DL; Juntti-Berggren L; Berggren PO; Bark C
    J Biol Chem; 2001 Sep; 276(36):34199-205. PubMed ID: 11443123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
    Asada A; Saito T; Hisanaga S
    J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.
    Zheng M; Leung CL; Liem RK
    J Neurobiol; 1998 May; 35(2):141-59. PubMed ID: 9581970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29.
    Patzke H; Tsai LH
    J Biol Chem; 2002 Mar; 277(10):8054-60. PubMed ID: 11784720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons.
    Kesavapany S; Amin N; Zheng YL; Nijhara R; Jaffe H; Sihag R; Gutkind JS; Takahashi S; Kulkarni A; Grant P; Pant HC
    J Neurosci; 2004 May; 24(18):4421-31. PubMed ID: 15128856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
    Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S
    Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.
    Cheng K; Li Z; Fu WY; Wang JH; Fu AK; Ip NY
    J Biol Chem; 2002 Aug; 277(35):31988-93. PubMed ID: 12084709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.
    Humbert S; Dhavan R; Tsai L
    J Cell Sci; 2000 Mar; 113 ( Pt 6)():975-83. PubMed ID: 10683146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
    Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
    J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
    Hallows JL; Chen K; DePinho RA; Vincent I
    J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo.
    Neystat M; Rzhetskaya M; Oo TF; Kholodilov N; Yarygina O; Wilson A; El-Khodor BF; Burke RE
    J Neurochem; 2001 Jun; 77(6):1611-25. PubMed ID: 11413244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.